V-027
(±)-O-去甲基文拉法辛-D6 溶液
100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
别名:
(±)−O-去甲基文拉法辛-D6 溶液
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C16H19D6NO2
化学文摘社编号:
分子量:
269.41
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
EC Number:
200-659-6
MDL number:
产品名称
(±)-O-去甲基文拉法辛-D6 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
InChI
1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3/i1D3,2D3
InChI key
KYYIDSXMWOZKMP-WFGJKAKNSA-N
SMILES string
OC1=CC=C(C(CN(C([2H])([2H])[2H])C([2H])([2H])[2H])C2(O)CCCCC2)C=C1
grade
certified reference material
form
liquid
feature
(Snap-N-Spike®)
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
concentration
100 μg/mL in methanol
technique(s)
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
application(s)
clinical testing
format
single component solution
storage temp.
−20°C
Quality Level
General description
经认证的参比溶液，适合用作内标，通过LC/MS或GC/MS定量尿液中O-去甲基文拉法辛水平或同位素稀释方法，以进行临床毒理学，尿液药物测试或法医分析。O-去甲基文拉法辛也称为去甲文拉法辛，是一种SNRI抗抑郁药，以商品名Pristiq®销售，用于治疗抑郁症。O-去甲基文拉法辛也是文拉法辛的主要尿代谢产物，文拉法辛是一种SNRI抗抑郁药，以Effexor®或Efexor出售，用于治疗重度抑郁症、广泛性焦虑症和其他与抑郁症相关的焦虑症。
Legal Information
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Effexor is a registered trademark of American Home Product Corp.
Pristiq is a registered trademark of Wyeth LLC
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
target_organs
Eyes
存储类别
3 - Flammable liquids
wgk
WGK 1
flash_point_f
49.5 °F
flash_point_c
9.7 °C
法规信息
危险化学品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持